MedSci Healthcare Holdings Limited (MEDSCI) filed its monthly return for the period ended 31 July 2026, confirming a stable capital structure and continued compliance with Hong Kong Stock Exchange (HKEX) listing requirements.

• Authorised capital remained unchanged at 15.00 billion ordinary shares with a par value of USD 0.0001, equivalent to USD 1.50 million.

• Issued share capital stood at 607.17 million ordinary shares. No treasury shares were held, and no changes in issued or treasury shares were recorded during the month.

• The company reported no activity under share options, warrants, convertibles, or other share-issuance arrangements.

• MEDSCI affirmed that its public float exceeded the minimum 25 percent threshold required by Main Board Rule 13.32B, ensuring market liquidity and regulatory compliance.

• The return was submitted to HKEX on 5 August 2026 and signed by Executive Director Dr. Zhang Fabao.